financetom
Business
financetom
/
Business
/
Verb Technology's Q3 Results to be 'Exceedingly Better' than Q2, CEO Says; Shares Jump Pre-Bell
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Verb Technology's Q3 Results to be 'Exceedingly Better' than Q2, CEO Says; Shares Jump Pre-Bell
Oct 17, 2024 2:42 PM

09:23 AM EDT, 10/14/2024 (MT Newswires) -- Verb Technology's ( VERB ) Q3 results will be "exceedingly better" than Q2 as its restructured businesses gain traction, Chief Executive Rory Cutaia said Monday in a letter to stockholders.

Shares of the company were up as much as 75% in recent premarket activity.

"It makes no sense to me that the stock should trade the way it does," Cutaia said, adding that Verb's stock should be trading at more than $22 per share given its low debt balance and years of cash runway. The stock last closed at $7.91.

Cutaia said Verb's Market.live e-commerce platform business has changed its model from a percent-of-client-sales model to a fixed-price, contract-based, and recurring revenue stream. The company also has another business vertical that is yet to be revealed, the CEO said.

The company's new Go Fund Yourself online show is "disrupting the equity crowd-funding sector," Cutaia said. It has a revenue model that includes cash and equity-based fees for appearances, with sales percentages from the show's shopping platform as well as revenue from sponsorships and advertisers.

Cutaia also defended the company's recent reverse stock split, which he said was unavoidable due to Nasdaq's delisting notice.

Price: 13.87, Change: +5.96, Percent Change: +75.35

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Moderna Insider Sold Shares Worth $1,756,177, According to a Recent SEC Filing
Moderna Insider Sold Shares Worth $1,756,177, According to a Recent SEC Filing
Jul 15, 2024
03:13 AM EDT, 07/15/2024 (MT Newswires) -- Noubar Afeyan, Director, on July 10, 2024, sold 15,000 shares in Moderna ( MRNA ) for $1,756,177. Following the Form 4 filing with the SEC, Afeyan has control over a total of 6,901,164 shares of the company, with 2,269,015 shares held directly and 4,632,149 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1682852/000095017024083327/xslF345X03/ownership.xml Price: 121.39, Change: -0.07,...
Palantir Technologies Insider Sold Shares Worth $1,031,233, According to a Recent SEC Filing
Palantir Technologies Insider Sold Shares Worth $1,031,233, According to a Recent SEC Filing
Jul 15, 2024
03:09 AM EDT, 07/15/2024 (MT Newswires) -- Alexander D. Moore, Director, on July 10, 2024, sold 37,077 shares in Palantir Technologies ( PLTR ) for $1,031,233. Following the Form 4 filing with the SEC, Moore has control over a total of 1,550,630 shares of the company, with 1,550,630 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1321655/000132165524000118/xslF345X03/wk-form4_1720828633.xml Price: 28.14, Change: +0.07, Percent Change:...
Apple's India sales hit $8 bln in year through March, Bloomberg News reports
Apple's India sales hit $8 bln in year through March, Bloomberg News reports
Jul 15, 2024
July 15 (Reuters) - Apple's ( AAPL ) sales in India hit a record of almost $8 billion in the year through March, Bloomberg News reported on Monday, citing a person familiar with the matter. Revenue in India jumped about 33% in the 12 months through March from $6 billion a year earlier, the report said. ...
Alnylam Pharmaceuticals Insider Sold Shares Worth $1,851,273, According to a Recent SEC Filing
Alnylam Pharmaceuticals Insider Sold Shares Worth $1,851,273, According to a Recent SEC Filing
Jul 15, 2024
03:05 AM EDT, 07/15/2024 (MT Newswires) -- Yvonne Greenstreet, Director, Chief Executive Officer, on July 11, 2024, sold 7,093 shares in Alnylam Pharmaceuticals ( ALNY ) for $1,851,273. Following the Form 4 filing with the SEC, Greenstreet has control over a total of 73,848 shares of the company, with 73,441 shares held directly and 407 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1178670/000173527624000075/xslF345X03/edgardoc.xml...
Copyright 2023-2026 - www.financetom.com All Rights Reserved